SS Innovations International Inc. (NASDAQ: SSII) is set to showcase its SSi Mantra surgical robotic system at the Society of Robotic Surgery (SRS) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The event, one of the largest gatherings of robotic surgery specialists, will highlight the company’s expanding clinical experience and growing focus on remote surgical capabilities. The SSi Mantra will be demonstrated throughout the conference and featured in multiple technical sessions, including a live robotic telesurgery broadcast from India, where a partial nephrectomy will be performed remotely (https://ibn.fm/FkgsY).
Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, will participate in several conference presentations covering telesurgery, robotic surgery adoption, and regulatory developments. The company’s participation underscores its commitment to advancing minimally invasive surgery through innovative technology. As of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, encompassing cardiac, pediatric, and telesurgical procedures. Approximately 2,100 physicians have been trained on the platform, which has been utilized across over 170 different surgical procedures.
The SSi Mantra system is designed to address the challenges of traditional surgery by offering enhanced precision, flexibility, and control. Its telesurgery capabilities are particularly significant, as they enable surgeons to perform procedures remotely, potentially expanding access to specialized care in underserved regions. The live broadcast from India will demonstrate the platform’s reliability and effectiveness in real-world scenarios, reinforcing its potential to transform surgical practices globally.
SS Innovations International is a developer of innovative surgical robotic technologies, and its presence at SRS 2026 reflects its growing influence in the field. The company’s clinical data, with over 12,000 procedures completed, provides evidence of the system’s safety and efficacy. The training of over 2,100 physicians indicates a robust adoption rate, which is critical for the platform’s continued expansion. The conference will also serve as a platform for discussing regulatory pathways and future applications of robotic surgery.
The broader implications of this announcement are significant. As robotic surgery becomes more prevalent, platforms like SSi Mantra could reduce surgical complications, shorten recovery times, and lower healthcare costs. Telesurgery, in particular, has the potential to bridge geographical gaps, allowing expert surgeons to operate on patients in remote locations. SS Innovations’ focus on these capabilities positions it as a key player in the evolving landscape of surgical technology. For investors, the company’s progress in clinical adoption and conference exposure may signal growth opportunities, though market competition and regulatory hurdles remain considerations.
